Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Jun 08, 2020 8:39pm

107 Views

Post# 31126817

RE:RE:RE:RE:RE:RE:Wino

SamiBan wrote:

You gotta pump it a little bit to keep hopes up don’t you think? Or else what could justify the 15% gain today?

You have to get used to the fact that if there are movements in the stock price without "official" news from the company or a new analyst report, you just won't know *why* the price moved. Yes, SPCEO has a "possible explanation" (or six) every time, but they are <informed> guesses, not reasons. There are a million reasons why it can move up & down ... but you would have to be omniscient to know in detail. The bottom line ... do *you* (or me) want to own the stock at this level? As for me, the answer is *YES*.

-LT

Bullboard Posts

New glaucoma treatment studied in a $3.4 billion market